Castle Biosciences, Inc.CSTLNASDAQ
Loading
Year-over-year total asset growth rate
5Y CAGR
-51.9%/yr
Long-term compound
Percentile
P52
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 2.80% |
| Q3 2025 | 3.31% |
| Q2 2025 | 8.57% |
| Q1 2025 | -5.56% |
| Q4 2024 | 3.24% |
| Q3 2024 | 5.59% |
| Q2 2024 | 6.28% |
| Q1 2024 | 1.14% |
| Q4 2023 | 3.97% |
| Q3 2023 | 2.50% |
| Q2 2023 | -0.35% |
| Q1 2023 | -4.57% |
| Q4 2022 | -2.29% |
| Q3 2022 | -0.12% |
| Q2 2022 | 3.14% |
| Q1 2022 | -3.92% |
| Q4 2021 | 6.66% |
| Q3 2021 | -0.42% |
| Q2 2021 | -0.41% |
| Q1 2021 | -0.45% |
| Q4 2020 | 108.81% |
| Q3 2020 | 4.39% |
| Q2 2020 | 67.60% |
| Q1 2020 | 0.43% |
| Q4 2019 | 5.78% |
| Q3 2019 | 239.46% |
| Q2 2019 | 7.69% |
| Q1 2019 | 38.21% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |